Latest Corporate News

Sun Pharma's ANDA for Azelastine Nasal Spray Gets FDA Nod

Mumbai-based drug maker Sun Pharmaceuticals has revealed that its abbreviated new drug application for Azelastine HCL nasal spray has been approved by

Mylan's ANDA for Clopidogrel Tablets Gets FDA Approval

Mylan Pharmaceuticals has revealed that the US Food and Drug Administration has approved its abbreviated new drug application for Clopidogrel tablets in 75mg and 300mg strengths.

Drug Marketing: Abbott Labs Fined (Dollor) 1.6 Billion

US authorities have announced that Abbott Laboratories has been fined (Dollor) 1.6 billion for marketing its anti-seizure medication Depakote for unauthorized uses.

The Cancer Cell Line Encyclopedia Launched by Novartis

A cancer cell line encyclopedia has been developed by Novartis and the Broad Institute. This encyclopedia catalogs the genetic and molecular profiles

LeGoo Maker Pluromed to be Acquired by Sanofi

Sanofi has revealed that it will buy the US company Pluromed . The French firm also said it will push for widespread adoption of its FDA- and EU-approved cardiovascular surgery aid LeGoo.

NGOs Protest Against Novartis' Glivec Lawsuit in India

Protests marked the annual meeting of Novartis as several NGOs protested against the attempt by the company to obtain a patent for its anti-cancer drug Glivec.

Allscripts Expanding India Operations

Allscripts - a major US healthcare IT firm is expanding its India operations to deliver healthcare information solutions to hospitals, reveals source.

Bio-Tech Medicine Proves to be Attractive for TCG Lifesciences

A top company official has confirmed that contract research company TCG Lifesciences will foray into the field of bio-tech medicine in the next two years.

Pfizer Initiates Recall of Birth Control Pills in the US

One million packets of birth control pills have been recalled by Pfizer in the US over a packaging error that could put women at risk of unintended pregnancy.

J (and) J Initiates Voluntary Recall of Aveeno Baby Lotion

After its baby lotion was found to contain excessive levels of bacteria, Johnson (and) Johnson announced that it will be recalling more than 2,000 tubes of its Aveeno Baby Calming Comfort Lotion.

Fortis to Launch Chain of Dialysis Centers to Broaden Access to Quality Care

Fortis Healthcare has announced that it will soon be launching a chain of dialysis centers across India, providing valuable service to patients suffering

Pacific Edge Buoyed by European Acceptance of Gastric Cancer Detection Patents

Patents for gastric cancer detection technology developed by biomedical company Pacific Edge have now been accepted in Europe, Australia and New Zealand, the company has announced.

FDA Approves Abbott's Xience Prime Coronary Stent

US based pharmaceutical company Abbott Labs has revealed that its everolimus-eluting coronary stent has been approved by the Food and Drug Administration for the treatment of coronary artery disease.

Circadian Technologies' Investigative Cancer Drug Receives FDA Nod for Clinical Trials

Australian biotechnology company, Circadian Technologies announced that its subsidiary company, Vegenics' New Drug Application for its investigative cancer

CooperVision Issues Another Statement Over Contact Lens Recall

Following the pressure applied by Food and Drug Administration US based eye-care company, CooperVision has released its second announcement regarding

Conditional Nod for Proposed Teva Buy

Teva Pharmaceutical Industries, the world's biggest generic drug maker, will receive a conditional green light from US regulators to its (Dollor) 6.8 billion acquisition of rival Cephalon.

P (and) G Takeover of Teva Drugs Division Receives EU Approval

The takeover by US consumer products giant Procter (and) Gamble of the 'over-the-counter' division of Israeli drugmaker Teva has received the approval of the European Commission.

GE Healthcare to Invest in Cancer Research

General Electric plans to invest (Dollor) 1 billion in cancer research over the next five years. GE chief executive Jeff Immelt and several venture capital

Genentech to Lodge Appeal for Saving Avastin

California based pharmaceutical company Genentech will be lodging an appeal with the US Food and Drug Administration and will be asking the regulator

GSK Gets FDA Nod for Epilepsy Drug

Pharmaceutical giant GlaxoSmithKline has announced that it has managed to get the approval from the US Food and Drug Administration to use its epilepsy

Aurobindo Pharma Gets USFDA Nod to Market Ramipril Tablets

Hyderabad based pharmaceutical company, Aurobindo Pharma has revealed that it has got the approval from the US Food and Drug Administration to manufacture

Pfizer Says FDA Has Given Green Signal for Virtual Clinical Study

Pharmaceutical giant Pfizer has revealed that it has received the go-ahead signal by the US Food and Drug Administration to conduct the first ever virtual clinical study in the country.

GSK to Slash Vaccine Price

For the world's poorest nations, drug giant GSK will cut 95 percent off the price of a diarrhea vaccine. This attempt would save hundreds of thousands of lives, says company's CEO.

Orexigen Says Will Halt Obesity Drug Development as FDA Demands are Unreasonable

California based pharmaceutical company Orexigen Therapeutics has announced that it will be stopping the development of its diet pill in the American

Pfizer Announces European Approval for Blood Thinner

American pharmaceutical giant Pfizer announced that it has gained the approval from the European Commission to market its newest blood thinner drug in the European market.

Pfizer's Lung Cancer Drug in Line for Shortened Schedule After Promising Results

Pfizer's new lung cancer drug has been placed on a shortened approval schedule by the US Food and Drug Administration following the results of a new study

InSound Launches Hearing Aid in Britain

InSound Medical has launched its new hearing aid in Britain that is being touted as the first "invisible" hearing aid due to the fact that the machine is pushed deep into the ear canal.

US Lawsuit Looms on Bayer Over Contraceptive

Bayer, the German pharma giant faces a US lawsuit on behalf of a teenager who died from a blood clot allegedly linked to its YAZ contraceptive. Michelle

Allergan Launches Painless Dermal Filler to Correct Facial Imperfections

American pharmaceutical giant Allergan announced the launch of their new product, the Juvederm XC, which the company claims is a painless dermal filler

Novartis Announces FDA Approval for Rare Pancreatic Cancer Drug

Swiss pharmaceutical giant Novartis has announced that its cancer drug Afinitor has received approval from the US Food and Drug Administration to be used in the treatment of a rare pancreatic cancer.

Merck Hepatitis C Drug Gets US Panel Nod

The Food and Drug Administration has been urged by a US government advisory committee to approve a new drug made by Merck to fight hepatitis C, a disease which attacks the liver.

Johnson (and) Johnson Acquires Synthes

Johnson (and) Johnson announced a 21.3 billion pounds takeover of Synthes, a US-Swiss medical technology, one of the biggest merger deals so far this year.

Rise in GlaxoSmithKline Profits

In the first quarter net profit of GlaxoSmithKline rose 14 percent to 1.525 billion pounds. GSK was rocked in September when the EU medicines regulator

Rwanda to Get Help from Merck, Qiagen to Tackle Cervical Cancer

In a new program to vaccinate girls and screen women for cervical cancer, Merck has announced yesterday that it is partnering with Qiagen and the government of Rwanda.

Bourn Hall Spreads Its Wings to Kochi, India

After making a mark as the world's first assisted conception clinic, Bourn Hall, founded by Prof Robert Edwards and Dr Patrick Steptoe, in U.K, is going

Dr Reddy's Gets FDA Approval to Market Fexofenadine

The US Food and Drug Administration has given its approval for a Abbreviated New Drug Application (ANDA) by Dr Reddy's Laboratories for the production of its Fexofenadine HCl tablets.

Strides Arcolab Receives FDA Approval to Market Product

One of India's leading drug manufacturers, Strides Arcolab has revealed that it has received approval from the US Food and Drug Administrator to market

Regulatory Approval Denied to Market Gardasil for Women Older Than 27

Merck was unable to get the nod from FDA to market Gardasil to women between the ages of 27 and 45. Federal drug regulators held their ground and denied

Jinx Reappears for AIM Medical Associates

AIM medical Associates, which conduct health checks for prospective porn movie stars and enables health services for the adult film industry, finds itself in the eye of a storm yet again.

Glenmark and GBR401

The discovery and initiated IND enabling studies of a Novel Biological Entity (NBE) lead candidate, GBR401 and anti-CD19 monoclonal antibody, has been

Sanofi-Aventis in Collaboration With Columbia University for Development of Diabetes Drugs

French pharmaceutical company Sanofi-Aventis has joined hands with the Columbia University Medical Center over a three year period to conduct a joint

Patent Approval for Products of Living Cell Technologies and HealthLinx

Encapsulation technology, IMMUPEL, by Living Cell Technologies (ASX:LCT) has received an Australian patent , while HealthLinx (ASX:HTX) has received a UK patent for its OvPlex diagnostic technology.

Severe Lung Disease in Patients With Diabetes may be Prevented by Leptin Resistance

A study conducted by researchers in Chicago says that resistance to leptin, a protein that plays a key role in regulating metabolism and appetite, may

Reforms In Regulatory System Needed For Pharmaceutical Growth

Experts have called for far-reaching reforms in the drug industry regulatory system in order to stimulate growth in the pharmaceutical sector. Researchers

Aurobindo Pharma Gets Tentative FDA Approval for Famciclovir

The US Food and Drug Administration has given a tentative approval for Aurobindo Pharma to market the generic Famciclovir tablets which are used to treat herpes virus infections.

US Trial of Cancer-Fighting Isotope to be Initiated by Areva

In some welcome news, a subsidiary of the French nuclear giant Areva revealed it had received US clearance to begin a clinical trial of an isotope that targets cancer cells.

Smith (and) Nephew Says Business as Usual

British medical devices maker, Smith (and) Nephew has revealed that it is yet to see any official letter from the US Food and Drug Administration (FDA) regarding

New Meningitis Vaccine from Novartis on the Anvil

A new vaccine against meningitis B is likely to be unveiled sometime next year with Novartis revealing that the jab has been successfully tested among humans.

Ranbaxy Subsidiary in Rs 605 Crore Deal to Supply Anti-HIV Drugs in SA

India's largest drug maker, Ranbaxy Laboratories has announced that its South African joint venture, Sonke Pharmaceuticals has won a mega deal worth Rs

What Companies Must Do to Improve Employee Morale During Recession

Corporates must do their best to engage with employees and boost their morale during an economic downturn. The model could help management identify